Lv41
768 积分 2026-03-20 加入
The immunology of vitiligo
9小时前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
7天前
已完结
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
7天前
已完结
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
7天前
已完结
Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis
7天前
已完结
Target identification and assessment in the era of AI
21天前
已完结
Spatial adaptation of eosinophils and their emerging roles in homeostasis, infection and disease
21天前
已完结
An up-to-date review of approved and emerging antibody therapies for idiopathic pulmonary fibrosis
27天前
已完结
An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: a look towards 2023 and beyond
27天前
已完结
Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials
27天前
已完结
皖公网安备34019202002308
